(E)-3-(4-Hydroxyphenyl)-N-(3-((4-((E)-3-(4-hydroxyphenyl)acrylamido)butyl)amino)propyl)acrylamide

Catalog No. :
ACTHSL078
CAS No. :
114916-05-1
Molecular Formula :
C25H31N3O4
Molecular Weight :
437.54

IUPAC Name:(E)-3-(4-hydroxyphenyl)-N-(3-((4-((E)-3-(4-hydroxyphenyl)acrylamido)butyl)amino)propyl)acrylamide

(E)-3-(4-Hydroxyphenyl)-N-(3-((4-((E)-3-(4-hydroxyphenyl)acrylamido)butyl)amino)propyl)acrylamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg95%$1030.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-3-(4-Hydroxyphenyl)-N-(3-((4-((E)-3-(4-hydroxyphenyl)acrylamido)butyl)amino)propyl)acrylamide
IUPAC Name(E)-3-(4-hydroxyphenyl)-N-(3-((4-((E)-3-(4-hydroxyphenyl)acrylamido)butyl)amino)propyl)acrylamide
MDL No.MFCD17214795
Molecular FormulaC25H31N3O4
Molecular Weight437.54
SMILESO=C(NCCCNCCCCNC(/C=C/C1=CC=C(O)C=C1)=O)/C=C/C2=CC=C(O)C=C2
InChI KeyQYBCBMVQSCJMSA-VOMDNODZSA-N
SynonymN1,N10-Bis(p-coumaroyl)spermidine;2-Propenamide,3-(4-hydroxyphenyl)-N-[3-[[4-[[3-(4-hydroxyphenyl)-1-oxo-2-propenyl]amino]butyl]amino]propyl]-,(E,E)- (9CI);N10-Bis(p-coumaroyl)spermidine
CAS No.114916-05-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACTHSL078 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTHSL078 route product structure diagram
    ACTHSL078114916-05-1
Inquiry

2. ACTHSL078 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTHSL078 route product structure diagram
    ACTHSL078114916-05-1
Inquiry

Comments (0)